Full Circle Lithium Corp. (TSXV:FCLI)

Ligand Pharmaceuticals Statistics

Total Valuation

TSXV:FCLI has a market cap or net worth of CAD 16.70 million. The enterprise value is 15.68 million.

Market Cap	16.70M
Enterprise Value	15.68M

Important Dates

The next estimated earnings date is Friday, September 26, 2025.

Earnings Date	Sep 26, 2025
Ex-Dividend Date	n/a

Share Statistics

TSXV:FCLI has 75.91 million shares outstanding. The number of shares has increased by 7.12% in one year.

Current Share Class	75.91M
Shares Outstanding	75.91M
Shares Change (YoY)	+7.12%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	29.19%
Owned by Institutions (%)	7.33%
Float	53.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	8.00
PS Ratio	20.14
PB Ratio	2.61
P/TBV Ratio	2.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.25
EV / Sales	18.91
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.59

Financial Position

The company has a current ratio of 2.34

Current Ratio	2.34
Quick Ratio	1.86
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-20,679.71

Financial Efficiency

Return on equity (ROE) is -51.83% and return on invested capital (ROIC) is -30.36%.

Return on Equity (ROE)	-51.83%
Return on Assets (ROA)	-28.19%
Return on Invested Capital (ROIC)	-30.36%
Return on Capital Employed (ROCE)	-53.99%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.11
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.13% in the last 52 weeks. The beta is 1.08, so TSXV:FCLI's price volatility has been similar to the market average.

Beta (5Y)	1.08
52-Week Price Change	-2.13%
50-Day Moving Average	0.25
200-Day Moving Average	0.29
Relative Strength Index (RSI)	46.78
Average Volume (20 Days)	24,231

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSXV:FCLI had revenue of CAD 829,060 and -3.69 million in losses. Loss per share was -0.05.

Revenue	829,060
Gross Profit	507,313
Operating Income	-3.45M
Pretax Income	-3.69M
Net Income	-3.69M
EBITDA	-3.06M
EBIT	-3.45M
Loss Per Share	-0.05

Balance Sheet

The company has 1.02 million in cash and n/a in debt, giving a net cash position of 1.02 million or 0.01 per share.

Cash & Cash Equivalents	1.02M
Total Debt	n/a
Net Cash	1.02M
Net Cash Per Share	0.01
Equity (Book Value)	6.40M
Book Value Per Share	0.08
Working Capital	771,775

Cash Flow

In the last 12 months, operating cash flow was -2.41 million and capital expenditures -399,841, giving a free cash flow of -2.81 million.

Operating Cash Flow	-2.41M
Capital Expenditures	-399,841
Free Cash Flow	-2.81M
FCF Per Share	-0.04

Margins

Gross Margin	61.19%
Operating Margin	-416.56%
Pretax Margin	-444.48%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSXV:FCLI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.12%
Shareholder Yield	n/a
Earnings Yield	-22.07%
FCF Yield	-16.81%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 1, 2023. It was a reverse split with a ratio of 0.8547009.

Last Split Date	May 1, 2023
Split Type	Reverse
Split Ratio	0.8547009

Scores

TSXV:FCLI has an Altman Z-Score of 17.67 and a Piotroski F-Score of 2.

Altman Z-Score	17.67
Piotroski F-Score	2